Tyvaso starter kit

Ended Awarded

Contract number
36C24121F0109
Awardee
Awarding agency
Obligated
$13,050

Award facts

Contract value 100% obligated
$13,050.45 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
West Haven, CT 06516, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the TYVASO STARTER KIT, which is a pharmaceutical product supplied by United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract is a Blanket Purchase Agreement (BPA) call under United Therapeutics' $50 million BPA with the U.S. Department of Veterans Affairs (VA) National Acquisition Center. This BPA allows the VA to efficiently procure United Therapeutics' portfolio of pulmonary arterial hypertension and oncology drugs, including Tyvaso, Remodulin, Orenitram, and Unituxin. The contract has a firm-fixed-price delivery order with a ceiling value of $13,050.45 and a period of performance through March 31, 2021. No set-aside designation was used for this commercial item procurement, and United Therapeutics is the prime contractor without any subcontractors. The contract is funded by the VA, which is a civilian agency that provides healthcare services to U.S. military veterans through its integrated service networks.

Quick answers

Who was awarded contract 36C24121F0109?

36C24121F0109 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 1 (Veterans Health Administration) on January 22, 2021.

How much is contract 36C24121F0109 worth?

The government has obligated $13,050 on 36C24121F0109.

Is contract 36C24121F0109 an order under another contract?

Yes. 36C24121F0109 is a BPA call under 36F79720D0104-36E79720A0008, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24121F0109 competed?

The extent of competition for 36C24121F0109 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award